Key Laboratory of Smart Drug Delivery (Ministry of Education), State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai 201203, People's Republic of China.
Biomed Mater. 2021 Feb 18;16(2):024104. doi: 10.1088/1748-605X/abdc97.
Pharmacotherapies for brain disorders are generally faced with obstacles from the blood-brain barrier (BBB). There are a variety of drug delivery systems that have been put forward to cross or bypass the BBB with the access to the central nervous system. Brain drug delivery systems have benefited greatly from the development of nanocarriers, including lipids, polymers and inorganic materials. Consequently, various kinds of brain drug delivery nano-systems have been established, such as liposomes, polymeric nanoparticles (PNPs), nanomicelles, nanohydrogels, dendrimers, mesoporous silica nanoparticles and magnetic iron oxide nanoparticles. The characteristics of their carriers and preparations usually differ from each other, as well as their transportation mechanisms into intracerebral lesions. In this review, different types of brain drug delivery nanocarriers are classified and summarized, especially their significant achievements, to present several recommendations and directions for future strategies of cerebral delivery.
治疗脑部疾病的药物疗法通常面临着血脑屏障 (BBB) 的障碍。有多种药物传递系统被提出,以通过中枢神经系统进入中枢神经系统。脑药物传递系统极大地受益于纳米载体的发展,包括脂质、聚合物和无机材料。因此,已经建立了各种脑药物传递纳米系统,例如脂质体、聚合物纳米粒子 (PNP)、纳米胶束、纳米水凝胶、树枝状大分子、介孔硅纳米粒子和磁性氧化铁纳米粒子。它们的载体和制剂的特性通常彼此不同,以及它们进入脑内病变的运输机制也不同。在这篇综述中,对不同类型的脑药物传递纳米载体进行了分类和总结,特别是它们的重要成就,为未来的脑传递策略提出了一些建议和方向。